Samip Vasaiwala, MD

Areas of research

09/2010 09/2012 F32 Grant Title: Stents and Antiplatelet Drugs: Impact on Ischemia and Bleeding in ElderlyFunding Agency: Agency for Healthcare Research and QualityRole: Principal Investigator2013-2016A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions. (ABSORB III). Sub-Investigator.2014-2017A Randomized, Comparative Effectiveness Study of Complete versus Culprit-only Revascularization Strategies to Treat Multi-Vessel Disease after Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. (COMPLETE) Sub-Investigator2014-2016Protocol Title: Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEichs Combo StEnt (Japan-USA HARMONEE): Assessment of a Novel DES Platform For Percutaneous Coronary Revascularization in Patients with Ischemic Coronary Disease and NSTEMI Acute Coronary Syndrome. Principal Investigator2015-2017Early Coronary Angiography Versus Delayed Coronary Angiography (PEARL). Principal Investigator.2015-2018 A prospective, multicenter, single-arm study designed to assess the safety of 3-month dual antiplatelet therapy (DAPT) in subjects at high risk for bleeding undergoing percutaneous coronary intervention (PCI) with the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY Stent System). Principal Investigator.2016-2018 A Prospective Multicenter Trial to Assess the Safety and Effectiveness of the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (Synergy Stent System) for the treatment of Atherosclerotic Lesion(s) (EVOLVE II). Principal Investigator.2017-2022 Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial. Principal Investigator2017 Heparin Versus Bivalirudin for Percutaneous Coronary Intervention for Stable Ischemic Heart Disease An Instrument Variable Analysis from the Norther New England Cardiovascular Disease Registry Presented at the American College of Cardiology Scientific Sessions 2018, Orlando, FL2017A comparison of systemic vascular resistance (SVR) estimates obtained by non-invasive methods to SVR obtained by invasive right heart catheterization (RHC). Principal Investigator.2017Emergency Physicians Accurately Identify Wall Motion Abnormalities in Acute Myocardial Infarction (WAMAMI) to be presented at the American Institute of Ultrasound in Medicine in Orlando, FL 20192017Impact of Snowfall Events on STEMI Care in Northern New England presented at AHA 20182017Impact of Renal Insufficiency on Major Adverse Cardiac Outcomes and Coronary Artery Revascularization. Presented at the Society of Coronary Angiography and Interventions (SCAI) Conference in San Diego, CA 20182018-2020Assessment of the WATCHMAN Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO). Sub-Investigator.